Expands Illumina’s Oncology Offerings for NextSeq™ 550Dx A Diagnostic Version of the Illumina TruSight™ Oncology 500 Assay Will Measure Potentially Predictive Genomic Biomarkers, Including Tumor Mutation Burden NEW YORK & SAN DIEGO–(BUSINESS WIRE)–Bristol-Myers Squibb Company (NYSE: BMY) and Illumina, Inc. (NASDAQ: ILMN) today announced a collaboration that will utilize Illumina’s next-generation sequencing (NGS) technology to develop and globally […]
– Developing systems for single-cell analysis and promoting their use in drug R&D and life-science studies – Yokogawa Electric Corporation (TOKYO: 6841) announces the establishment on April 1 of a Single Cellome*1 Co-innovators’ Consortium with research groups led by Professor Kenichiro Todoroki and Assistant Professor Hajime Mizuno of the Laboratory of Analytical and Bioanalytical Chemistry, School […]
Tokyo, Japan – Hitachi High-Technologies Corporation (TSE:8036, Hitachi High-Tech) announced Hitachi High-Tech’ s capital participation in OmniSeq®,Inc. (OmniSeq), which is a molecular diagnostics subsidiary of the Roswell Park Comprehensive Cancer Center, which was the first institution to focus exclusively on cancer research. Hitachi High-Tech has made the field of biotechnology and healthcare its priority. Amid […]
Scientists in North America can now benefit from the high contrast, label-free, live cell imaging provided by Livecyte™, following the appointment of Bulldog Bio as the Phasefocus™ distributor for USA and Canada. This announcement signals the start of an exciting time for Phasefocus, as the company seeks to make headway on its initial achievements and […]
SOUTH SAN FRANCISCO, Calif. — Fluidigm Corporation (NASDAQ:FLDM) today announced the introduction of the Advanta™ CFTR NGS Library Prep Assay, a highly efficient and scalable next-generation sequencing (NGS) library prep workflow for sequencing of the CFTR (cystic fibrosis transmembrane conductance regulator) gene. Cystic fibrosis (CF) is a complex, multisystem disease that is caused by mutations in the […]
AACR 2018 Annual Meeting includes 40-plus abstracts covering QIAGEN Sample to Insight solutions Germantown, Maryland, and Hilden, Germany, April 12, 2018 – QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today launched two novel liquid biopsy panels to evaluate circulating tumor cells (CTCs) in the growing field of research into molecular mechanisms in prostate and lung […]
Extends Horizon’s biomanufacturing capabilities into vaccine manufacture Research supported by a grant from the Canadian International Development Research Centre, funded by the Bill and Melinda Gates foundation Cambridge, UK: Horizon Discovery Group plc (LSE: HZD) (“Horizon” or “the Group”), a global leader in the application of gene editing and gene modulation to deliver inspired […]
St. Jude Children’s Research Hospital, in collaboration with Microsoft and DNAnexus, offers extensive next-generation sequencing data and unique analysis tools to accelerate research and cures for life-threatening pediatric diseases St. Jude Children’s Research Hospital today launched St. Jude Cloud, an online data-sharing and collaboration platform that provides researchers access to the world’s largest public repository […]
Global leader in organ-on-a-chip technology backed by international syndicate for worldwide commercial expansion and new product development Leiden, the Netherlands — MIMETAS, leader in organ-on-a-chip products and tissue models, has secured 20.5 million USD in financing from an international syndicate from Asia and Europe. MIMETAS will use the proceeds of this Series B financing round to expand […]
MENLO PARK, Calif. — Pacific Biosciences of California, Inc. (Nasdaq:PACB), the leader in long-read, high-resolution sequencing, today announced that the HudsonAlpha Institute for Biotechnology is using the organization’s newest Sequel® Sequencing System to support the goal of dramatically increasing the diagnostic success rate in challenging pediatric clinical cases. Led by faculty investigator Greg Cooper, Ph.D., the institution’s NIH-funded Clinical Sequencing Exploratory Research (CSER) […]
Pay Invoice
Latest Blogs
-
Laboratory Tool Companies’ Dividends Show Stability
September 29, 2026 10:14 am
-
Automation Provides a Boost for Sample Prep Instrument Market Growth
August 25, 2026 11:49 am
-
SDi Predicts a Recovery Amid Headwinds
July 24, 2026 2:51 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
